Orchid Pharma Ltd
NSE:ORCHPHARMA
Orchid Pharma Ltd
NSE:ORCHPHARMA
Price:
777
INR
0.14%
Market Closed
Market Cap:
39.4B
INR
Balance Sheet
Balance Sheet Decomposition
Orchid Pharma Ltd
Orchid Pharma Ltd
| Current Assets | 8.3B |
| Cash & Short-Term Investments | 2.5B |
| Receivables | 2.2B |
| Other Current Assets | 3.7B |
| Non-Current Assets | 8B |
| Long-Term Investments | 525.1m |
| PP&E | 6.6B |
| Intangibles | 185.9m |
| Other Non-Current Assets | 745.3m |
Balance Sheet
Orchid Pharma Ltd
Orchid Pharma Ltd
Currency: INR
Millions
Annual
| Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
3 906
|
3 149
|
2 571
|
3 056
|
3 255
|
1 740
|
199
|
81
|
306
|
2 665
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
3 906
|
3 149
|
2 571
|
3 056
|
3 255
|
1 740
|
199
|
81
|
306
|
2 665
|
|
| Short-Term Investments |
0
|
1 069
|
22
|
23
|
31
|
1
|
151
|
0
|
2
|
45
|
|
| Total Receivables |
1 809
|
2 700
|
1 647
|
1 195
|
1 897
|
1 274
|
1 902
|
2 231
|
2 161
|
1 972
|
|
| Accounts Receivables |
2 566
|
2 700
|
1 647
|
1 195
|
1 199
|
680
|
1 357
|
1 706
|
2 152
|
1 955
|
|
| Other Receivables |
757
|
0
|
0
|
0
|
698
|
594
|
545
|
525
|
10
|
16
|
|
| Inventory |
6 002
|
2 418
|
2 113
|
1 937
|
1 698
|
1 417
|
1 529
|
1 727
|
2 287
|
2 642
|
|
| Other Current Assets |
1 064
|
390
|
399
|
578
|
794
|
1 261
|
1 718
|
460
|
253
|
583
|
|
| Total Current Assets |
12 781
|
9 727
|
6 751
|
6 789
|
7 675
|
5 693
|
5 499
|
4 499
|
5 010
|
7 908
|
|
| PP&E Net |
19 305
|
17 779
|
16 500
|
15 255
|
14 044
|
8 588
|
6 775
|
5 931
|
6 192
|
6 360
|
|
| PP&E Gross |
19 305
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 192
|
6 360
|
|
| Accumulated Depreciation |
11 127
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6 371
|
6 692
|
|
| Intangible Assets |
514
|
1 393
|
1 348
|
1 322
|
1 300
|
248
|
4
|
3
|
4
|
149
|
|
| Goodwill |
948
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
5 578
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
513
|
513
|
|
| Long-Term Investments |
8
|
304
|
237
|
208
|
174
|
17
|
44
|
503
|
513
|
518
|
|
| Other Long-Term Assets |
1 480
|
8 384
|
7 719
|
7 679
|
7 577
|
53
|
51
|
169
|
20
|
91
|
|
| Other Assets |
948
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
40 614
N/A
|
37 587
-7%
|
32 556
-13%
|
31 254
-4%
|
30 770
-2%
|
14 599
-53%
|
12 373
-15%
|
11 106
-10%
|
12 252
+10%
|
15 539
+27%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3 112
|
3 798
|
4 331
|
3 588
|
3 024
|
1 016
|
1 100
|
1 677
|
1 818
|
2 296
|
|
| Accrued Liabilities |
204
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
|
| Short-Term Debt |
6 466
|
6 338
|
5 995
|
6 943
|
6 955
|
0
|
28
|
228
|
1 410
|
140
|
|
| Current Portion of Long-Term Debt |
701
|
2 033
|
3 499
|
6 137
|
0
|
624
|
224
|
369
|
416
|
3
|
|
| Other Current Liabilities |
744
|
823
|
1 277
|
3 457
|
13 476
|
109
|
69
|
133
|
76
|
160
|
|
| Total Current Liabilities |
11 227
|
12 991
|
15 102
|
20 125
|
23 455
|
1 749
|
1 421
|
2 408
|
3 719
|
2 600
|
|
| Long-Term Debt |
24 940
|
23 775
|
21 568
|
18 939
|
14 246
|
5 040
|
4 275
|
2 082
|
1 488
|
1 208
|
|
| Deferred Income Tax |
1 112
|
978
|
494
|
32
|
32
|
32
|
32
|
32
|
32
|
0
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
42
|
79
|
59
|
75
|
77
|
118
|
115
|
110
|
126
|
36
|
|
| Total Liabilities |
37 320
N/A
|
37 823
+1%
|
37 223
-2%
|
39 171
+5%
|
37 811
-3%
|
6 939
-82%
|
5 843
-16%
|
4 632
-21%
|
5 366
+16%
|
3 844
-28%
|
|
| Equity | |||||||||||
| Common Stock |
853
|
890
|
890
|
890
|
890
|
408
|
408
|
408
|
408
|
507
|
|
| Retained Earnings |
1 092
|
1 125
|
5 557
|
8 807
|
7 930
|
7 252
|
6 121
|
6 066
|
6 478
|
11 187
|
|
| Additional Paid In Capital |
4 497
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
965
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
3 294
N/A
|
236
N/A
|
4 667
-1 878%
|
7 918
-70%
|
7 040
+11%
|
7 660
N/A
|
6 529
-15%
|
6 474
-1%
|
6 886
+6%
|
11 695
+70%
|
|
| Total Liabilities & Equity |
40 614
N/A
|
37 587
-7%
|
32 556
-13%
|
31 254
-4%
|
30 770
-2%
|
14 599
-53%
|
12 373
-15%
|
11 106
-10%
|
12 252
+10%
|
15 539
+27%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
41
|
41
|
41
|
41
|
51
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
